Table 2. Changes in eCO and Blood Eosinophils Levels Over 3 Weeks.
| Baseline | 1 week | 2 weeks | 3 weeks | |
|---|---|---|---|---|
| CO (ppm) | ||||
| I_PUFA | 3.7 ± 0.7 | 3.5 ± 1.4 | 2.8 ± 0.5a | 2.4 ± 0.5a |
| N_PUFA | 4.7 ± 0.9 | 3.7 ± 0.9 | 2.9 ± 0.4a | 2.4 ± 0.6a |
| Control | 2.9 ± 0.4b | 2.7 ± 0.5 | 2.3 ± 0.3 | 2.5 ± 0.6 |
| Eosinophilic (%) | ||||
| I_PUFA | 5.7 ± 1.7 | 5.9 ± 1.9 | 4.8 ± 1.0 | 5.4 ± 2.0 |
| N_PUFA | 2.9 ± 1.5 | 2.8 ± 1.1 | 2.7 ± 1.8 | 3.1 ± 1.3 |
| Control | 1.8 ± 0.5 | 2.2 ± 0.5 | 2.3 ± 1.0 | 2.0 ± 0.6 |
Data are presented as mean ± SD. aP < 0.05: compared to baseline. bP < 0.05 compared to I_PUFA and PUFA. PUFA: polyunsaturated fatty acid; I_PUFA: intake of PUFA and FeNO ≥ 25 ppb; N_PUFA: intake of PUFA and FENO < 25 ppb and eCO ≥ 3.6 ppm; eCO: exhaled carbon monoxide; SD: standard deviation.